Advertisement

AngioDynamics, Inc. ANGO

Set alert

Price alert · ANGO

All alert types
11.99 USD -0.36 -2.91%

At close · Oct 30

11.99 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
11.99 × 2
Ask
12.00 × 2
11.89 Day range 12.34
9.70 52-week range 16.13
YTD
-6.62%
1 year
-1.24%
Open
12.32
Prev close
12.35
Mkt cap
504.23M
Vol
475.83K
Avg vol
643.04K
EPS
-0.78
P/E
0.00
Div yield
0.00%
More statistics
Low
11.89
High
12.34
Forward P/E
-36.21
Beta
0.67
Short ratio
2.88
Inst. own
81.31%
Dividend
0.00
Ex-div date
Earnings
Jan 8, 2025
50-d avg
7.35
200-d avg
6.77
1y target
13.00

2Y chart

Chart tools
Interval

Events in this range
  • Dec 10, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Jan 8, 2025Earnings: —; estimate -0.11; surprise —%
Signals (107)
NameDateAgo
MACD: Buy SignalOct 23, 20261 week ago
SMA: BearishOct 8, 20263 weeks ago
RSI: OversoldOct 8, 20263 weeks ago
SMA: BearishOct 6, 20263 weeks ago
SMA: BullishOct 5, 20263 weeks ago
SMA: BearishOct 1, 20261 month ago
MACD: Sell SignalAug 20, 20262 months ago
MACD: Buy SignalAug 19, 20262 months ago
RSI: OverboughtAug 19, 20262 months ago
MACD: Sell SignalAug 18, 20262 months ago
RSI: OverboughtAug 7, 20262 months ago
MACD: Buy SignalJul 28, 20263 months ago
MACD: Sell SignalJul 23, 20263 months ago
MACD: Buy SignalJul 15, 20263 months ago
RSI: OverboughtJul 15, 20263 months ago
MACD: Sell SignalJul 8, 20263 months ago
RSI: OverboughtJun 25, 20264 months ago
MACD: Buy SignalJun 22, 20264 months ago
MACD: Sell SignalJun 17, 20264 months ago
MACD: Buy SignalJun 5, 20264 months ago
SMA: BullishJun 4, 20264 months ago
SMA: BullishJun 2, 20265 months ago
SMA: BearishJun 1, 20265 months ago
SMA: BearishJun 1, 20265 months ago
MACD: Sell SignalJun 1, 20265 months ago
SMA: BullishMay 19, 20265 months ago
MACD: Buy SignalMay 19, 20265 months ago
MACD: Sell SignalMay 12, 20265 months ago
SMA: BearishMay 11, 20265 months ago
SMA: BullishMay 6, 20265 months ago
SMA: BearishMay 4, 20266 months ago
SMA: BullishMay 1, 20266 months ago
SMA: BullishApr 30, 20266 months ago
SMA: BearishApr 29, 20266 months ago
SMA: BearishApr 29, 20266 months ago
SMA: BullishApr 22, 20266 months ago
SMA: BullishApr 22, 20266 months ago
SMA: BearishApr 20, 20266 months ago
SMA: BullishApr 17, 20266 months ago
MACD: Buy SignalApr 17, 20266 months ago
MACD: Sell SignalApr 6, 20266 months ago
SMA: BearishApr 2, 20267 months ago
SMA: BearishApr 2, 20267 months ago
SMA: BullishMar 31, 20267 months ago
SMA: BullishMar 25, 20267 months ago
SMA: BullishMar 25, 20267 months ago
MACD: Buy SignalMar 25, 20267 months ago
SMA: BearishMar 12, 20267 months ago
SMA: BearishMar 12, 20267 months ago
SMA: BullishMar 11, 20267 months ago
SMA: BullishMar 10, 20267 months ago
SMA: BearishMar 6, 20267 months ago
MACD: Sell SignalMar 5, 20268 months ago
SMA: BearishMar 3, 20268 months ago
SMA: BullishFeb 25, 20268 months ago
SMA: BullishFeb 10, 20268 months ago
MACD: Buy SignalJan 30, 20269 months ago
SMA: BearishJan 16, 20269 months ago
SMA: BullishJan 15, 20269 months ago
SMA: BearishJan 8, 20269 months ago
RSI: OversoldJan 7, 20269 months ago
SMA: BearishJan 6, 20269 months ago
MACD: Sell SignalDec 17, 202510 months ago
RSI: OverboughtDec 3, 202511 months ago
MACD: Buy SignalDec 1, 202511 months ago
SMA: BullishNov 21, 202511 months ago
SMA: BearishNov 20, 202511 months ago
MACD: Sell SignalNov 14, 202511 months ago
MACD: Buy SignalNov 12, 202511 months ago
MACD: Sell SignalOct 31, 20251 year ago
MACD: Buy SignalOct 15, 20251 year ago
MACD: Sell SignalOct 7, 20251 year ago
MACD: Buy SignalOct 2, 20251 year ago
RSI: OverboughtOct 2, 20251 year ago
MACD: Sell SignalSep 16, 20251 year ago
RSI: OverboughtAug 28, 20251 year ago
SMA: BullishAug 25, 20251 year ago
SMA: BullishAug 22, 20251 year ago
MACD: Buy SignalAug 12, 20251 year ago
MACD: Sell SignalAug 1, 20251 year ago
MACD: Buy SignalJul 24, 20251 year ago
SMA: BearishJul 1, 20251 year ago
SMA: BullishJun 30, 20251 year ago
SMA: BearishJun 27, 20251 year ago
MACD: Sell SignalJun 17, 20251 year ago
SMA: BullishMay 27, 20251 year ago
SMA: BearishMay 22, 20251 year ago
SMA: BullishMay 19, 20251 year ago
SMA: BearishMay 13, 20251 year ago
SMA: BullishMay 12, 20251 year ago
MACD: Buy SignalMay 12, 20251 year ago
MACD: Sell SignalMay 1, 20251 year ago
MACD: Buy SignalApr 24, 20251 year ago
MACD: Sell SignalApr 21, 20251 year ago
MACD: Buy SignalApr 14, 20251 year ago
MACD: Sell SignalApr 7, 20251 year ago
SMA: BearishApr 3, 20251 year ago
SMA: BullishApr 2, 20251 year ago
MACD: Buy SignalMar 17, 20251 year ago
RSI: OversoldMar 10, 20251 year ago
SMA: BearishFeb 21, 20251 year ago
MACD: Sell SignalJan 27, 20251 year ago
RSI: OverboughtJan 15, 20251 year ago
MACD: Buy SignalJan 8, 20251 year ago
RSI: OverboughtJan 8, 20251 year ago
MACD: Sell SignalDec 27, 20241 year ago
RSI: OverboughtDec 9, 20241 year ago

Key statistics

Market cap
353.11M
Enterprise value
311.65M
Trailing P/E
0.00
Forward P/E
-36.21
PEG ratio
0.00
Price / sales
1.21
Price / book
1.81
EPS (TTM)
-6.05
Beta
0.67
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-83.02%
Revenue (TTM)
292.73M
Revenue growth
-14.20%
Free cash flow
24.19M
Total cash
55.01M
Total debt
5.42M
Return on equity
-77.85%
Shares outstanding
40.63M
Short % of float
3.42%
50-day average
7.35
200-day average
6.77

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 13.00 +8.4% upside
Target (low)
12.00
Target (mean)
13.00
Target (high)
14.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Jan 8, 2025

Expected Jan 8, 2025. Consensus EPS estimate -0.11.

Earnings history

Financials — quick view

All financials
ANGO Revenue — quarterly 80.92M
2023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 20262027-Q1 2026
ANGO Net income — quarterly -7.10M
2023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 20262027-Q1 2026
ANGO EPS — quarterly -0.17
2023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 20262027-Q1 2026

Earnings

ANGO recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Jan 8, 2025Nov 1, 2024-0.11———
Oct 3, 2024Aug 1, 2024-0.15-0.11+0.04+26.67%
Jul 16, 2024May 1, 2024-0.20-0.06+0.14+70.00%
Apr 4, 2024Feb 1, 2024-0.14-0.16-0.02-14.29%
Jan 5, 2024Nov 1, 2023-0.09-0.05+0.04+44.44%
Oct 4, 2023Aug 1, 2023-0.14-0.12+0.02+14.29%

Upgrades / downgrades

ANGO analyst upgrades and downgrades
DateFirmActionFromTo
Dec 10, 2024HC Wainwright & Co.reitBuyBuy
Oct 4, 2024HC Wainwright & Co.reitBuyBuy
Oct 4, 2024Canaccord GenuitymainBuyBuy
Sep 20, 2024HC Wainwright & Co.reitBuyBuy
Jul 17, 2024Canaccord GenuitymainBuyBuy
Jul 17, 2024HC Wainwright & Co.reitBuyBuy

About AngioDynamics, Inc.

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States

News

Your note

Sign in to keep a note on ANGO — it syncs with the Stock Master app.

Insider holders

ANGO insider holders
InsiderRelationLatest transactionDateShares held
AUEN EILEEN O SHEADirectorStock Award(Grant)Jul 16, 202487,043
CAMPBELL CHAD THOMASOfficerStock Award(Grant)Jul 16, 202465,366
CLEMMER JAMES CChief Executive OfficerPurchaseOct 6, 2024681,582
DONNELLY HOWARD WDirectorStock Award(Grant)Jul 16, 2024149,376
JOHNSON WESLEY E JRDirectorStock Award(Grant)Jul 16, 2024125,863
LAWRENCE WEISS TOfficerStock Award(Grant)Dec 1, 202452,697

Institution ownership

ANGO institution ownership
Holder% heldSharesValueReported
Blackrock Inc.11.47%4,660,41940.50MSep 29, 2024
Systematic Financial Management, L.P.5.93%2,410,34620.95MSep 29, 2024
Vanguard Group Inc5.64%2,289,85519.90MSep 29, 2024
Millennium Management Llc5.50%2,235,45219.43MSep 29, 2024
Dimensional Fund Advisors LP3.33%1,353,66011.76MSep 29, 2024
Renaissance Technologies, LLC2.60%1,056,8149.18MSep 29, 2024

Fund ownership

ANGO fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.95%1,198,94710.42MSep 29, 2024
iShares Russell 2000 ETF2.43%985,5478.56MOct 30, 2024
Vanguard Extended Market Index Fund1.62%659,9585.74MSep 29, 2024
Royce Small-Cap Opportunity Fund1.40%569,4104.95MSep 29, 2024
College Retirement Equities Fund-Stock Account1.15%467,1804.06MSep 29, 2024
Fidelity Small Cap Index Fund0.96%389,3093.38MAug 30, 2024
Advertisement